Serrated polyps and colorectal cancer: New pathway to malignancy

Annual Review of Pathology: Mechanisms of Disease

Volumn 4, Issue , 2009, Pages 343-364

  Noffsinger, Amy E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adenoma; Colon carcinoma; CpG island methylator phenotype; Hyperplastic polyp; Microsatellite instability

Indexed keywords

B RAF KINASE; DNA; EPHRIN RECEPTOR B2; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; CANCER GROWTH; CANCER RISK; COLON ADENOCARCINOMA; COLON POLYP; COLORECTAL ADENOMA; COLORECTAL CANCER; CPG ISLAND; DNA METHYLATION; GENE MUTATION; HUMAN; HYPERPLASIA; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOLECULAR BIOLOGY; MORPHOLOGY; MUTATION; NONHUMAN; PHENOTYPE; POLYPOSIS; PRIORITY JOURNAL; RECTUM ADENOMA; REGULATORY MECHANISM; REVIEW; ADENOCARCINOMA; ADENOMA; ANIMAL; CELL TRANSFORMATION; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PRECANCER; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ADENOMA; ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC POLYPS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; PRECANCEROUS CONDITIONS; SIGNAL TRANSDUCTION;

EID: 66149095468     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev.pathol.4.110807.092317     Document Type: Review

References (138)

1. Goldman H, Ming S, Hickok DF. 1970. Nature and significance of hyperplastic polyps of the human colon. Arch. Pathol. 89:349-354
2. Eide TJ. 1986. Prevalence and morphological features of adenomas of the large intestine in individuals with and without colorectal carcinoma. Histopathology 10:111-118
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, et al. 1988. Genetic alterations during colo-rectal tumor development. N. Engl. J. Med. 319:525-532 (Pubitemid 18215829)
4. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, et al. 1993. Clues to the pathogenesis of familial colorectal cancer. Science 260:812-816 (Pubitemid 23167611)
5. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, et al. 1996. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res. 56:4836-4840 (Pubitemid 26374414)
6. Iino H, Simms L, Young J, Arnold J, Winship IM, et al. 2000. DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary nonpolyposis colorectal cancer. Gut 47:37-42 (Pubitemid 30430409)
7. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, et al. 1995. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338
8. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, et al. 1997. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275:967-969 (Pubitemid 27087710)
9. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, et al. 1996. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat. Genet. 14:225-227
10. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. 1993. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561 (Pubitemid 23186645)
11. Kinzler KW, Vogelstein B. 1996. Lessons from hereditary colorectal cancer. Cell 87:159-170
12. Salahshor S, Kressner U, Pahlman L, Glimelius B, Lindmark G, Lindblom A. 1999. Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer 26:247-252 (Pubitemid 29468345)
13. Jass JR, Biden KG, Cummings M, Simms LA, Walsh M, et al. 1999. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J. Clin. Pathol. 52:455-460 (Pubitemid 29281765)
14. Jass JR, Barker M, Fraser L, Walsh MD, Whitehall VL, et al. 2003. APC mutation and tumour budding in colorectal cancer. J. Clin. Pathol. 56:69-73 (Pubitemid 36132478)
15. Wong NACS, Morris RG, McCondochie A, Bader S, Jodrell DI, Harrison DJ. 2002. Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on β-catenin protein dysregulation, but not k-ras mutation. J. Pathol. 197:128-135 (Pubitemid 34450172)
16. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, et al. 2000. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signaling. Nat. Genet. 26:146-147 (Pubitemid 30764494)
17. Thorstensen L, Lind GE, Lovig T, Diep CB, Meling GI, et al. 2005. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia 7:99-108 (Pubitemid 40315987)
18. Longacre TA, Fenoglio-Preiser CF. 1990. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am. J. Surg. Pathol. 14:524-537
19. Azimuddin K, Stasik JJ, Khubchandani IT, Rosen L, Riether RD, Scarlatto M. 2000. Hyperplastic polyps: "more than meets the eye"? Report of sixteen cases. Dis. Colon Rectum 43:1309-1313 (Pubitemid 30703492)
20. Warner AS, Glick ME, Fogt F. 1994. Multiple large hyperplastic polyps of the colon coincident with adenocarcinoma. Am. J. Gastroenterol. 89:123-125 (Pubitemid 24020067)
21. Urbanski SJ, Kossakowska AE, Marcon N, Bruce WR. 1984. Mixed hyperplastic adenomatous polyps: an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp. Am. J. Surg. Pathol. 8:551-556 (Pubitemid 14083982)
22. Jeevaratnam P, Cottier DS, Browett PJ, van de Water NS, Pokos V, Jass JR. 1996. Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J. Pathol. 179:20-25 (Pubitemid 26180082)
23. Renaut AJ, Douglas PR, Newstead GL. 2002. Hyperplastic polyposis of the colon and rectum. Colorectal Dis. 4:213-215
24. Torlakovic E, Snover DC. 1996. Serrated adenomatous polyposis in humans. Gastroenterology 110:748-755
25. Hawkins NJ, Ward RL. 2001. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J. Natl. Cancer Inst. 93:1307-1313 (Pubitemid 32910571)
26. Makinen MJ, George SM, Jernvall P, Makela J, Vihko P, Karttunen TJ. 2001. Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis. J. Pathol. 193:286-294 (Pubitemid 32229858)
27. Goldstein NS, Bhanot P, Odish E, Hunter S. 2003. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am. J. Clin. Pathol. 119:778-796 (Pubitemid 37047838)
28. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. 2003. Morphologic reappraisal of serrated colorectal polyps. Am. J. Surg. Pathol. 27:65-81 (Pubitemid 36014900)
29. DiSario JA, Foutch PG, Mai HD, Pardi K, Manne RK. 1991. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am. J. Gastroenterol. 32:641-652
30. Higuchi T, Sugihara K, Jass JR. 2005. Demographic and pathological characteristics of serrated polyps of the colorectum. Histopathology 47:32-40 (Pubitemid 40978811)
31. Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, et al. 2008. Sessile serrated adenoma (SSA) versus traditional serrated adenoma (TSA). Am. J. Surg. Pathol. 32:21-29
32. Lazarus R, Junttila OE, Karttunen TJ, Makinen MJ. 2005. The risk of metachronous neoplasia in patients with serrated adenoma. Am. J. Clin. Pathol. 123:349-359 (Pubitemid 40315075)
33. Jamarillo E, Watanabe M, Rubio C, Slezak P. 1997. Small colorectal serrated adenomas: endoscopic findings. Endoscopy 29:1-3 (Pubitemid 27116853)
34. Matsumoto T, Mizuno M, Shimizu M, Manabe T, Iida M. 1999. Clinicopathologic features of serrated adenoma of the colorectum: comparison with traditional adenoma. J. Clin. Pathol. 52:513-516 (Pubitemid 29309209)
35. Matsumoto T, Mizuno M, Shimizu M, Manabe T, Iida M, Fujishima M. 1999. Serrated adenoma of the colorectum: colonoscopic and histologic features. Gastrointest. Endosc. 49:736-742 (Pubitemid 29269674)
36. Oka S, Tanaka S, Hiyama T, Ito M, Kitadai Y, et al. 2004. Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types. Gastrointest. Endosc. 59:213-219 (Pubitemid 38199214)
37. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VLJ, et al. 2006. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131:1400-1407 (Pubitemid 44708940)
38. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. 2005. Serrated polyps of the large intestine. A morphologic and molecular review of an evolving concept. Am. J. Clin. Pathol. 124:380-391 (Pubitemid 41232924)
39. Williams GT, Arthur JF, Bussey HJR, Morson BC. 1980. Metaplastic polyps and polyposis of the colorectum. Histopathology 4:155-170
40. Abeyasundara H, Hampshire P. 2002. Hyperplastic polyposis associated with synchronous adenocarcinomas of the transverse colon. ANZ. J. Surg. 71:686-687 (Pubitemid 33071037)
41. Bengoechea O, Martinez-Penuela JM, Larringa B, Valerdi J, Borda F. 1987. Hyperplastic polyposis of the colorectum and adenocarcinoma in a 24-year-old man. Am. J. Surg. Pathol. 11:323-327 (Pubitemid 17049082)
42. Ferrandez A, Samowitz W, DiSario JA, Burt RW. 2004. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am. J. Gastroenterol. 99:2012-2018 (Pubitemid 39421248)
43. Jorgensen H, Mogensen AM, Svendsen LB. 1996. Hyperplastic polyposis of the large bowel. Three cases and a review of the literature. Scand. J. Gastroenterol. 31:825-830 (Pubitemid 26255054)
44. Keljo DJ, Weinberg AG, Winick N, Tomlinson G. 1998. Rectal cancer in an 11-year-old girl with hyperplastic polyposis. J. Pediatr. Gastroenterol. Nutr. 28:327-332 (Pubitemid 29293660)
45. Koide N, Saito Y, Fujii T, Kondo H, Saito D, Shimoda T. 2002. A case of hyperplastic polyposis of the colon with adenocarcinomas in hyperplastic polyps after long-term follow-up. Endoscopy 34:499-502 (Pubitemid 34601062)
46. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J. 2001. Hyperplastic polyposis: association with colorectal cancer. Am. J. Surg. Pathol. 25:177-184 (Pubitemid 32167499)
47. Lieverse RJ, Kibbelaar RE, Griffioen G, Lamers CB. 1995. Colonic adenocarcinoma in a patient with multiple hyperplastic polyps. Neth. J. Med. 46:185-188
48. McCann BG. 1988. A case of metaplastic polyposis of the colon associated with focal adenomatous change and metachronous adenocarcinomas. Histopathology 13:700-702
49. Orii S, Nakamura S, Sugai T, Habano W, Akasaka I, et al. 1997. Hyperplastic (metaplastic) polyposis of the colorectum associated with adenomas and an adenocarcinoma. J. Clin. Gastroenterol. 25:369-372 (Pubitemid 28006272)
50. Shepherd NA. 1993. Inverted hyperplastic polyposis of the colon. J. Clin. Pathol. 46:56-60
51. Teoh HH, Delahunt B, Isbister WH. 1989. Dysplastic and malignant areas in hyperplastic polyps of the large intestine. Pathology 21:138-142 (Pubitemid 20036639)
52. Jass JR, Iino H, Ruszkiewicz A, Painter D, Solomon MJ, et al. 2000. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 47:43-49 (Pubitemid 30430410)
53. Yao T, Nishiyama K, Oya M, Douzuki T, Kajiwara M, Tsuneyoshi M. 2000. Mutliple "serrated adenocarcinomas" of the colon with a cell lineage common to metaplastic polyps and serrated adenoma: case report of a new subtype of colonic adenocarcinoma with gastric differentiation. J. Pathol. 190:444-449 (Pubitemid 30163584)
54. Chow E, Lipton L, Lynch E, D'Souza R, Aragona C, et al. 2006. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 131:30-39 (Pubitemid 44015745)
55. Hyman NH, Anderson P, Blasyk H. 2004. Hyperplastic polyposis and the risk of colorectal cancer. Dis. Colon Rectum 47:2101-2104 (Pubitemid 40179073)
56. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardello FM, Hamilton SR. 2000. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 119:323-332 (Pubitemid 30621982)
57. Burt R, Jass JR. 2000. Hyperplastic polyposis. In Pathology and Genetics of Tumours of the Digestive System. Vol.2: World Health Organization Classification of Tumours, ed. SR Hamilton, LA Aaltonen, pp. 135-136 Lyon: IARC
58. Tuppurainen K, Makinen JM, Junttila O, Liakka A, Kyllonen AP, et al. 2005. Morphology and microsatellite instability in sporadic serrated and nonserrated colorectal cancer. J. Pathol. 207:285-294 (Pubitemid 41556452)
59. Makinen MJ. 2007. Colorectal serrated adenocarcinoma. Histopathology 50:131-150
60. Dong SM, Lee EJ, Jeon ES, Park CK, Kim KM. 2005. Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod. Pathol. 18:170-178
61. Young J, Jass JR. 2006. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol. Biomark. Prev. 15:1778-1784 (Pubitemid 44664248)
62. Tanaka H, Deng G, Matsuzaki K, Kakar S, Kim GE, et al. 2006. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than nonmucinous colorectal cancer. Int. J. Cancer 118:2765-2771 (Pubitemid 43673355)
63. Biemer-Huttmann AE, Walsh MD, McGuckin MA, Ajioka Y, Watanabe H, et al. 1999. Immunohistochemical staining patterns of MUC1, MUC2, MUC4 and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J. Histochem. Cytochem. 47:1039-1048 (Pubitemid 29379903)
64. Biemer-Huttmann AE, Walsh MD, McGuckin MA, Simms LA, Young J, et al. 2000. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin. Cancer Res. 6:1909-1916
65. Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. 2001. Histopathological identification of colon cancer with microsatellite instability. Am. J. Pathol. 158:527-535 (Pubitemid 32158613)
66. Whitehall VL, Wynter CV, Walsh MD, Simms LA, Purdie D, et al. 2002. Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. Cancer Res. 62:6011-6014
67. Greenson JK, Bonner JD, Ben-Yzhak O, Cohen HI, Miselevich I, et al. 2003. Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am. J. Surg. Pathol. 27:563-570 (Pubitemid 36514468)
68. Laiho P, Kokko A, Vanharanta S, Salovaara R, Sammalkorpi H, et al. 2007. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene 26:312-320 (Pubitemid 46095743)
69. Ajioka Y, Watanabe H, Jass JR, Yokota Y, Kobayashi M, Nishikura K. 1998. Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum. Gut 42:680-684 (Pubitemid 28261056)
70. Uchida H, Ando H, Maruyama K, Kobayashi H, Toda H, et al. 1998. Genetic alterations of mixed hyperplastic adenomatous polyps in the colon and rectum. Jpn. J. Cancer Res. 89:299-306 (Pubitemid 28197295)
71. Sawyer EJ, Cerar A, Hanby AM, Gorman P, Arends M, et al. 2002. Molecular characteristics of serrated adenomas. Gut 51:200-206
72. Yamamoto T, Konishi K, Yomochi T, Makino R, Kaneko K, et al. 2003. No major tumorigenic role for β-catenin in serrated as opposed to conventional colorectal adenomas. Br. J. Cancer 89:152-157 (Pubitemid 36897951)
73. Jass JR, Whitehall VL, Young J, Leggett BA. 2002. Emerging concepts in colorectal neoplasia. Gastroenterology 123:862-876
74. Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, et al. 2006. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathology 49:121-131
75. O'Brien MJ, Shi Y, Clebanoff JL, Mulcahy E, Farraye FA, et al. 2004. Hyperplastic (serrated) polyps of the colorectum. Relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am. J. Surg. Pathol. 28:423-434 (Pubitemid 38436515)
76. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, et al. 2006. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am. J. Surg. Pathol. 30:1491-1501 (Pubitemid 44808785)
77. Barry EL, Baron JA, Grau MV, Wallace K, Haile RW. 2006. K-ras mutation in incident sporadic colorectal adenomas. Cancer 106:1046-1140 (Pubitemid 43297341)
78. Guerrero S, Casanova I, Farre L, Mazo A, Capella G, Mangues R. 2000. K-ras codon 12 mutations induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. Cancer Res. 60:6750-6756
79. Maltzman T, Knoll K, Martinez ME, Byers T, Stevens BR, et al. 2001. K-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology 121:302-309 (Pubitemid 32729377)
80. Otori K, Oda K, Sugiyama K, Hasebe T, Mukai K, et al. 1997. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut 40:660-663 (Pubitemid 27278336)
81. Chan TL, Zhao W, Cancer Genome Proj., Leung SY, Yuen ST. 2003. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res. 63:4878-4881 (Pubitemid 37022620)
82. Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ. 2004. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am. J. Surg. Pathol. 28:1452-1459 (Pubitemid 39425511)
83. Kambara T, Simms L, Whitehall VLJ, Spring KJ, Wynter CVA, et al. 2004. BRAF mutation and CpG island methylation: an alternative pathway to colorectal cancer. Gut 53:1137-1144
84. Zauber P, Sabbath-Solitare M, Marotta S, Zauber A, Bishop T. 2004. Comparative molecular pathology of sporadic hyperplastic polyps and neoplastic lesions from the same individual. J. Clin. Pathol. 57:1084-1088 (Pubitemid 39331361)
85. Higashidani Y, Tamura S, Morita T, Tadokoro T, Yokoyama Y, et al. 2003. Analysis of K-ras codon 12 mutation in flat and nodular variants of serrated adenoma in the colon. Dis. Colon Rectum 46:327-332 (Pubitemid 36331650)
86. Yashiro M, Laghi L, Saito K, Carethers JM, Slezak P, et al. 2005. Serrated adenomas have a pattern of genetic alterations that distinguishes them from other colorectal polyps. Cancer Epidemiol. Biomark. Prev. 14:2253-2256 (Pubitemid 41603275)
87. Baccarini M. 2002. An old kinase on a new path: Raf and apoptosis. Cell Death Differ. 9:783-785 (Pubitemid 34885079)
88. Mercer KE, Pritchard CA. 2003. Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta 1653:25-40
89. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949-954 (Pubitemid 34716871)
90. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. 2002. Tumorigenesis: RAF/RAS oncogenes and mismatch repair status. Nature 418:934
91. Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, et al. 2002. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res. 62:6451-6455 (Pubitemid 35364105)
92. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, et al. 2006. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38:787-793 (Pubitemid 43980599)
93. McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, et al. 2004. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary nonpolyposis colon cancer syndrome from sporadic MSI-H colon cancer. Fam. Cancer 3:101-107 (Pubitemid 40645891)
94. Beach R, Chan AO, Wu TT, White JA, Morris JS, et al. 2005. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am. J. Pathol. 166:1069-1075 (Pubitemid 40524431)
95. Konishi K, Yamochi T, Makino R, Kaneko K, Yamamoto T, et al. 2004. Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin. Cancer Res. 10:3082-3090 (Pubitemid 38619687)
96. Batlle E, Henderson JT, Beghtel H, Van Den Born MM, Sancho E, et al. 2002. β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrin B. Cell 111:251-263 (Pubitemid 35292445)
97. Elowe S, Holland SJ, Kulkarni S, Pawson T. 2001. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol. Cell Biol. 21:7429-7441 (Pubitemid 32953493)
98. Tateyama H, Li W, Takahashi E, Miura Y, Sugiura H, Eimoto T. 2002. Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorecturm: The saw-toothed structure may be related to inhibition of apoptosis. Am. J. Surg. Pathol. 26:249-256 (Pubitemid 34127506)
99. Horkko TT, Makinen MJ. 2003. Colorectal proliferation and apoptosis in serrated versus conventional adenoma-carcinoma pathway: growth, progression and survival. Scand. J. Gastroenterol. 38:1241-1248
100. Komori K, Ajioka Y, Watanabe H, Oda K, Nimura Y. 2003. Proliferation kinetics and apoptosis of serrated adenoma of the colorectum. Pathol. Int. 53:277-283 (Pubitemid 36737022)
101. Ladas SD, Kitsanta P, Triantafyllou K, Tzanthas C, Spiliadi C, Raptis SA. 2005. Cell turnover of serrated adenomas. J. Pathol. 206:62-67
102. Mitomi H, Sada M, Kobayashi K, Igarashi M, Mori A, et al. 2003. Different apoptotic activity and p21WAF1/CIP1, but not p27Kip1, expression in serrated adenomas as compared with traditional adenomas and hyperplastic polyps of the colorectum. J. Cancer Res. Clin. Oncol. 129:449-455 (Pubitemid 37056151)
103. Jubb AM, Bell SM, Quirke P. 2001. Methylation and colorectal cancer. J. Pathol. 195:111-134
104. Robertson KD, Wolffe AP. 2000. DNA methylation in health and disease. Nat. Rev. Genet. 1:11-19
105. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. 1999. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96:8681-8686 (Pubitemid 29354851)
106. Ogino S, Kawasaki T, Kirkner G, Ogawa A, Dorfman I, et al. 2006. Down-regulation of p21 (CDKN1A/CIP 1) is inversely associated with microsatellite instability and the CpG island methylator phenotype (CIMP) in colorectal cancer. J. Pathol. 210:147-154 (Pubitemid 44463929)
107. Park SJ, Rashid A, Lee J-H, Kim SG, Hamilton SR, Wu T-T. 2003. Frequent CpG island methylation in serrated adenomas of the colorectum. Am. J. Pathol. 162:815-822 (Pubitemid 36237490)
108. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. 2002. Concordant CpG island methylation in hyperplastic polyposis. Am. J. Pathol. 160:529-536 (Pubitemid 34160330)
109. Kondo Y, Issa JP. 2004. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 23:29-39
110. van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B. 2002. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51:797-802 (Pubitemid 35408598)
111. Hawkins N, Norrie M, Cheong K, Mokany E, Ku SL, et al. 2002. CpG island methylation in sporadic colorectal cancer and its relationship to microsatellite instability. Gastroenterology 122:1376-1387 (Pubitemid 34465180)
112. Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, et al. 2006. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55:1467-1474 (Pubitemid 44476793)
113. Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Grieu F, et al. 2006. DNA hypermethylation in normal colonic mucosa of patients with colorectal cancer. Br. J. Cancer 94:593-598 (Pubitemid 43289765)
114. Oh K, Redston M, Odze RD. 2005. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum. Pathol. 36:101-111 (Pubitemid 40215639)
115. Young J, Simms LA, Biden KG, Wynter C, Whitehall V, et al. 2001. Features of colorectal cancers with high-level microsatellite instability occurring in familial and nonfamilial settings: parallel pathways of tumorigenesis. Am. J. Pathol. 159:2107-2116 (Pubitemid 33104265)
116. Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR. 2001. Methylation of O-6-methylguanine- DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res. 61:827-830 (Pubitemid 32174386)
117. Noda H, Kato Y, Yoshikawa H, Arai M, Togashi K, et al. 2005. Microsatellite instability caused by hMHL1 promoter methylation increases with tumor progression in right-sided sporadic colorectal cancer. Oncology 69:354-362 (Pubitemid 41752805)
118. Kuismanen SA, Holmberg MT, Salovaara R, Schweizer P, Aaltonen LA, et al. 1999. Epigenetic phenotypes distinguish microsatellite-stable and unstable colorectal cancers. Proc. Natl. Acad. Sci. USA 96:12661-12666 (Pubitemid 29513559)
119. Kuismanen SA, Homberg MT, Salovaara R, de la Chapelle A, Peltomaki P. 2000. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am. J. Pathol. 156:1773-1779 (Pubitemid 30646714)
120. Wynter CVA, Walsh MD, Higuchi T, Leggett BA, Young J, Jass JR. 2004. Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut 53:573-580 (Pubitemid 38372984)
121. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, et al. 2005. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 65:6063-6069 (Pubitemid 40994390)
122. Frazier ML, Xi L, Zong J, Viscofsky N, Rashid A, et al. 2003. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res. 63:4805-4808 (Pubitemid 37022610)
123. Vandrovcova J, Lagerstedt-Robinsson K, Pahlman L, Lindblom A. 2006. Somatic BRAF V600E mutations in familial colorectal cancer. Cancer Epidemiol. Biomark. Prev. 15:2270-2273 (Pubitemid 44877055)
124. Peltomaki P, Aaltonen LA, Sistonen P, Pylkkanen L, Mecklin JP, et al. 1993. Genetic mapping of a locus predisposing to human colorectal cancer. Science 260:812-816 (Pubitemid 23167610)
125. Thibodeau SN, Bren G, Schaid D. 1993. Microsatellite instability in cancer of the proximal colon. Science 260:816-819 (Pubitemid 23167612)
126. Worthley DL, Walsh MD, Barker M, Ruszkiewicz A, Bennett G, et al. 2005. Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer. Gastroenterology 128:1431-1436 (Pubitemid 40712192)
127. Deng G, Bell I, Crawley S, Gum J, Terdiman JP, et al. 2004. BRAF mutation is frequently present in sporadic colorectal cancer with methylated MLH1, but not in hereditary nonpolyposis colorectal cancer. Clin. Cancer Res. 10:191-195 (Pubitemid 38114179)
128. Jass JR. 2005. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat. Clin. Pract. Oncol. 2:398-405
129. Halford S, Sasieni P, Rowan A, Wasan H, Bodmer W, et al. 2002. Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res. 62:53-57 (Pubitemid 34073985)
130. Halford SER, Sawyer EJ, Lambros MB, Gorman P, Macdonald ND, et al. 2003. MSI-low, a real phenomenon which varies in frequency among cancer types. J. Pathol. 201:289-294 (Pubitemid 37408259)
131. Tomlinson I, Ilyas M, Johnson V, Davies A, Clark G, et al. 1998. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer. J. Pathol. 184:148-152 (Pubitemid 28088422)
132. Jass JR. 2007. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50:113-130 (Pubitemid 44953403)
133. Goldstein NS. 2006. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am. J. Clin. Pathol. 125:132-145
134. Goldstein NS. 2005. Clinical significance of (sessile) serrated adenomas: another piece of the puzzle. Am. J. Clin. Pathol. 123:329-330
135. Jass JR. 2001. Serrated route to colorectal cancer: back street or super highway? J. Pathol. 193:283-285
136. Yamauchi T, Watanabe M, Hasegawa H, Yamamoto S, Endo T, et al. 2002. Serrated adenoma developing into advanced colon cancer in 2 years. J. Gastroenterol. 37:467-470 (Pubitemid 34846290)
137. Makinen JM, Makinen MJ, Karttunen TJ. 2002. Serrated adenocarcinoma of the rectum associated with perianal Paget's disease: a case report. Histopathology 41:177-179
138. Cunningham KS, Riddell RH. 2006. Serrated mucosal lesions of the colorectum. Curr. Opin. Gastroenterol. 22:48-53